PIC Therapeutics is a biotechnology company focused on fundamentally changing how we treat cancer by developing a new generation of therapeutics based on the modulation of RNA translation.
PIC Therapeutics was founded on the seminal work of Dr. Gerhard Wagner, a professor at Harvard Medical School world-renowned for his scientific expertise in protein structure and his research on interactions of eukaryotic translation initiation factors (eIFs).
PIC Therapeutics, led by President and CEO Dr. Kathy Bowdish, was launched to translate these discoveries into small molecule precision therapeutics to benefit cancer patients.
Our precision-based therapeutics target the “master switch” of cancer signaling pathways, selectively blocking oncogene protein production by modulating the Pre-Initiation Complex (PIC) that drives their mRNA translation. Our selective approach has the potential to simultaneously modulate multiple oncogenic drivers leading to a powerful new generation of cancer-treating therapeutics.
Location: United States, Massachusetts, Natick
Employees: 11-50
Total raised: $40M
Founded date: 2016
Investors 3
Date | Name | Website |
28.10.2022 | Lumira Ven... | lumiravent... |
30.08.2023 | OrbiMed | orbimed.co... |
- | Advent Lif... | adventls.c... |
Funding Rounds 2
Date | Series | Amount | Investors | Deal News |
25.10.2022 | Series A | $35M | - | vcnewsdail... |
15.04.2020 | Seed | $5M | - | vcnewsdail... |
Mentions in press and media 8
Date | Title | Description | Source |
20.10.2022 | PIC Therapeutics Closes $35M Series A Financing | PIC Therapeutics, a Natick, MA-based biopharmaceutical company, raised $35M in Series A funding. Th... | finsmes.co... |
19.10.2022 | PIC Therapeutics Completes $35 Million Series A Financing to... | - | orbimed.co... |
19.10.2022 | PIC Therapeutics Inks $35M Series A Financing | NATICK, MA, PIC Therapeutics, announced the closing of a $35 million Series A financing led by Orb... | vcnewsdail... |
19.10.2022 | Lumira Ventures Participates In The Closing of PIC Therapeut... | October 19, 2022 – PIC Therapeutics, Inc., a biopharmaceutical company dedicated to developing life-... | lumiravent... |
15.04.2020 | PIC Therapeutics Raises $5M in Seed Funding | PIC Therapeutics, a Boston, MA-based biotechnology company focused on transforming the treatment of ... | finsmes.co... |
15.04.2020 | PIC Therapeutics Raises $5 Million | BOSTON--(BUSINESS WIRE)--PIC Therapeutics, a biotechnology company focused on transforming the treat... | citybizlis... |
15.04.2020 | PIC Therapeutics Picks Up $5M Seed Funding | BOSTON, MA, PIC Therapeutics has closed a $5M Series Seed round of preferred equity funding. >... | vcnewsdail... |
- | PIC Therapeutics | “Cancer Research | PIC Therapeutics | mRNA” | fastfounde... |